Loading...
605033 logo

Shaanxi Meibang Pharmaceutical Group Co., Ltd.SHSE:605033 Stock Report

Market Cap CN¥2.3b
Share Price
n/a
1Y-12.0%
7D10.9%
1D10.0%
Portfolio Value
View

Shaanxi Meibang Pharmaceutical Group Co., Ltd.

SHSE:605033 Stock Report

Market Cap: CN¥2.3b

Shaanxi Meibang Pharmaceutical Group (605033) Stock Overview

Engages in the research and development, production, sale, and agricultural technology promotion, and service of pesticide products in China and internationally. More details

605033 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance4/6
Financial Health5/6
Dividends2/6

605033 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW473,694 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
BL
BlackGoat
IN
Investingwilly
RO
RockeTeller
DA
davidlsander
473,694 investors already sharing narratives

Shaanxi Meibang Pharmaceutical Group Co., Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Shaanxi Meibang Pharmaceutical Group
Historical stock prices
Current Share PriceCN¥18.70
52 Week HighCN¥34.69
52 Week LowCN¥15.81
Beta0.44
1 Month Change12.38%
3 Month Change-19.54%
1 Year Change-12.04%
3 Year Change-1.48%
5 Year Changen/a
Change since IPO2.35%

Recent News & Updates

Recent updates

Analysis Article Feb 13

Shaanxi Meibang Pharmaceutical Group Co., Ltd.'s (SHSE:605033) Popularity With Investors Under Threat As Stock Sinks 27%

The Shaanxi Meibang Pharmaceutical Group Co., Ltd. ( SHSE:605033 ) share price has softened a substantial 27% over the...
Analysis Article Dec 23

Getting In Cheap On Shaanxi Meibang Pharmaceutical Group Co., Ltd. (SHSE:605033) Is Unlikely

Shaanxi Meibang Pharmaceutical Group Co., Ltd.'s ( SHSE:605033 ) price-to-earnings (or "P/E") ratio of 52.8x might make...
Analysis Article Sep 05

Shaanxi Meibang Pharmaceutical Group's (SHSE:605033) Weak Earnings Might Be Worse Than They Appear

Shaanxi Meibang Pharmaceutical Group Co., Ltd.'s ( SHSE:605033 ) stock wasn't much affected by its recent lackluster...

Shareholder Returns

605033CN ChemicalsCN Market
7D10.9%1.6%-1.5%
1Y-12.0%23.6%7.7%

Return vs Industry: 605033 underperformed the CN Chemicals industry which returned 23.6% over the past year.

Return vs Market: 605033 underperformed the CN Market which returned 7.7% over the past year.

Price Volatility

Is 605033's price volatile compared to industry and market?
605033 volatility
605033 Average Weekly Movement4.7%
Chemicals Industry Average Movement8.0%
Market Average Movement7.4%
10% most volatile stocks in CN Market12.4%
10% least volatile stocks in CN Market4.4%

Stable Share Price: 605033 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 605033's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19981,117Tong Zhangwww.meibang.cn

Shaanxi Meibang Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research and development, production, sale, and agricultural technology promotion, and service of pesticide products in China and internationally. The company offers pesticides, plant nutrients, fungicides, insecticides, acaricides, herbicides, plant growth regulators, fertilizers, and microbial fertilizers. It is also involved in sale of agricultural machinery.

Shaanxi Meibang Pharmaceutical Group Co., Ltd. Fundamentals Summary

How do Shaanxi Meibang Pharmaceutical Group's earnings and revenue compare to its market cap?
605033 fundamental statistics
Market capCN¥2.30b
Earnings (TTM)CN¥54.33m
Revenue (TTM)CN¥958.88m
46.5x
P/E Ratio
2.6x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
605033 income statement (TTM)
RevenueCN¥0
Cost of RevenueCN¥0
Gross ProfitCN¥0
Other ExpensesCN¥0
EarningsCN¥0

Last Reported Earnings

Jun 30, 2026

Next Earnings Date

n/a

Earnings per share (EPS)0.40
Gross Margin33.30%
Net Profit Margin5.67%
Debt/Equity Ratio13.3%

How did 605033 perform over the long term?

See historical performance and comparison

Dividends

0.8%
Current Dividend Yield
37%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/30 15:12
End of Day Share Price 2026/07/30 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Shaanxi Meibang Pharmaceutical Group Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.